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List of abbreviations  
b. wt.  body weight 
HPLC  high-performance liquid chromatography 
PAP   peroxidase-antiperoxidase method 
RIA   radioimmunoassay 
RT   room temperature 
TFA   trifluoroacetic acid 
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1. Introduction  
Oxytocin is a neuropeptide synthesized mainly in the paraventricular and supraoptic 
nuclei of the hypothalamus. As one of the classical neurohormones, oxytocin is transported to 
the neurohypophysis where it is stored and released to the blood circulation. It plays an 
important role in neuroendocrine regulation of parturition and lactation. Oxytocin is present 
not only in the hypothalamo-neurohypophyseal system, but is also located in various areas of 
the central and peripheral nervous system.  Furthermore, numerous studies have shown that 
oxytocin mRNA is present in peripheral tissues such as decidua, chorion, amnion, ovary, 
testis and heart. Locally synthetized oxytocin can stimulate uterine contractions in the time of 
parturition in a paracrine fashion without increasing circulating maternal oxytocin 
concentrations. Actions of local oxytocin in the ovary are linked to luteinization, luteolysis 
and steroidogenesis. It may be involved in the local control of androgen biosynthesis and 
spermatogenesis in the testis. The heart and large vessels like aorta and vena cava are also 
sites of oxytocin synthesis and the locally produced oxytocin may have important regulatory 
functions within the heart and the vascular system.  
1.1 Oxytocin in the spinal cord 
A growing body of knowledge has accumulated on the location, origin, putative roles and 
regulation of oxytocin in the spinal cord. The majority of oxytocin-containing fibers in the 
spinal cord were shown to arise from the hypothalamic paraventricular nucleus. 
Oxytocinergic fibers descending from the paraventricular nucleus make contacts with 
preganglionic neurons in the rat spinal cord, as demonstrated by a combination of retrograde 
cell body labelling and immunocytochemistry. Oxytocinergic terminals were found in the 
dorsal horn, central gray and intermediolateral column by means of electron microscopic 
immunocytochemistry. The distribution of the oxytocinergic hypothalamo-spinal neuronal 
projections shows a good overlap with that of the spinal oxytocin receptors, supporting the 
view that oxytocin acts as a neurotransmitter in the central nervous system. Several lines of 
evidence suggest that central oxytocin is an endogenous modulator of various spinal 
functions. It has been shown to induce spinal antinociception through activation of oxytocin 
receptors. In addition, several studies indicate the involvement of oxytocin in the regulation of 
spinal autonomic functions: it can inhibit sympathetic preganglionic neurons of the spinal 
cord, plays an important role in the control of penile erection and male sexual behaviour, 
mediates the pupillary dilatation response to vaginocervical stimulation, modulates the 
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micturition reflex as well as uterine motility, and it can increase the heart rate and renal 
sympathetic activity. Experiments have also been directed at defining physiological and 
pharmacological stimuli that can alter the spinal levels of oxytocin. Spinal oxytocin displays 
cyclic variations during the stages of the rat estrous cycle, suggesting that it may be regulated 
by ovarian hormones. Evidence has been provided for a direct estrogen-dependent release of 
oxytocin within the spinal cord in response to vaginocervical stimulation. Various other 
stimuli, such as immobilization stress, isotonic or hypertonic saline also affect the oxytocin 
content in the spinal cord. In addition, oxytocin release from spinal cord synaptosomes seems 
to be under inhibitory control of opioid peptides.  
1.2 Oxytocin in the peripheral nervous system 
Data available on the occurrence, origin and role of oxytocin in the peripheral system 
is yet scanty. Oxytocin immunoreactivity was localized by immunohistochemistry in neurons 
of rat sensory ganglia and characterized by high-performance liquid chromatography. 
Immunoreactive oxytocin detected in extracts of human lumbar sympathetic paravertebral 
ganglia was identified chromatographically as being authentic oxytocin. Occurence of 
oxytocin has been also revealed in peripheral nerves. Recently, transcripts for oxytocin and its 
receptor was found in ganglion cells of myenteric and submucosal plexuses. In addition, 
oxytocin and oxytocin receptor proteins have been demonstrated by immunohistochemistry in 
the enteric nervous system of the rat.  
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1.3 Rationale and objectives 
I. Although several studies have reported the localization of oxytocin- and/or 
neurophysin-immunoreactive fibers in the rat spinal cord, most of them lack a detailed 
analysis of their segmental distribution. The only truly detailed and comprehensive 
study demonstrated exclusively neurophysin I (the carrier protein of oxytocin) 
staining, presumably due to more intense staining obtained for neurophysin as 
compared to oxytocin. We have therefore sought to examine the distribution of 
oxytocin-immunoreactive neuronal elements in the rat spinal cord, using a specific 
oxytocin antibody for light and electron microscopic immunocytochemical 
localization and quantitation by RIA.  
II. Central histaminergic neurons have been shown to be involved in the control of 
oxytocin secretion under various physiological conditions including parturition and 
lactation, and both central and peripheral administration of histamine increases plasma 
oxytocin level. However, the literature falls short of providing sufficient data about the 
effect of peripheral histamine administration on the oxytocinergic neuronal systems of 
the central nervous system. Our objective was to examine whether oxytocin levels 
change in the spinal cord after peripheral administration of histamine.  
III. There is scanty information available on the occurrence of oxytocin in the peripheral 
nervous system. In order to obtain data in the human, sensory and sympathetic ganglia 
as well as peripheral nerves have been examined for the presence of oxytocin using 
high-performance liquid chromatography and radioimmunoassay.     
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2. Subjects and methods  
2.1 Identification of immunoreactive oxytocin in rat spinal cord  
2.1.1 Light microscopic immunohistochemistry 
The experiments were carried out on 12 male CFY rats weighing 200 - 310 g. The 
animals were anaesthetized with sodium pentobarbital and perfused through the heart with 
isotonic saline solution followed by 4% paraformaldehyde in 0.1 M phosphate buffer (pH 
7.4). The spinal cords were then removed and kept in the same fixative for 4-5 hours. 
Transverse and horizontal sections 50-70 µm thick were cut on a Vibratome (Oxford 
Instruments). Oxytocin was localized by means of the peroxidase-antiperoxidase (PAP) 
method, using a rabbit antiserum to oxytocin.   
2.1.2 Electron microscopic immunocytochemistry 
Four male CFY rats weighing 200-310 g were anaesthetized with sodium 
pentobarbital and perfused through the heart with isotonic salt solution followed by a fixative 
containing 4% paraformaldehyde and 0.5% glutaraldehyde in 0.1 M phosphate buffer (pH 
7.4). Subsequently, the spinal cords were removed and kept in the same fixative for 4-5 hours. 
For preembedding staining, 40-50 µm thick cross-sections were cut with Vibratome. The 
sections were infiltrated with 30% sucrose, rapidly frozen in liquid nitrogen and thawed in 0.1 
M phosphate buffer. Oxytocin immunoreactivity was localized by means of the PAP method. 
The Vibratome sections were osmicated, dehydrated and embedded. Finally, ultrathin sections 
were made and examined under the electron microscope.   
2.1.3 Radioimmunoassay (RIA) 
Twenty male CFY rats of 220-250 g body weight were decapitated and their spinal 
cords were quickly dissected into cervical, thoracic, lumbar, sacral and coccygeal regions. 
Tissue samples were sonicated in ice-cold 1.0 M HCl. Subsequently, phosphate buffer was 
added and the pH was adjusted to 4.0. An aliquot of the homogenate was kept for 
determination of the protein content. The remainder was centrifugated, and oxytocin was 
extracted from the supernatant using thermally activated Vycor glass powder. The evaporated 
residues of the extraction were redissolved in RIA buffer. Oxytocin was determined in 
duplicate by RIA. Results were calculated statistically by two-way ANOVA without 
interaction, followed by Scheffe s test for multiple comparison. 
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2.1.4 Measurement of oxytocin after histamine treatment 
The experiments were performed in male Wistar rats weighing 180-220 g. The 
animals were maintained on a 14 h light/10 h dark cycle (lights on between 06.00 and 20.00 
h)  and allowed to consume standard food and tap water ad libitum. They were injected 
intraperitoneally (i.p.) with an aqueous solution of histamine dihydrochloride in a dose of 20 
mg/kg b. wt. The controls received physiological saline in the same volume. Fifteen min after 
the treatment the animals were killed by decapitation. Subsequently, the spinal cords were 
removed and their oxytocin contents were determined by RIA. The statistical evaluation was 
performed with the Student s t-test.   
2.2 Chromatographical characterization of oxytocin in human ganglia and  
peripheral  nerves  
Four pieces of Gasserian ganglia, two pieces of L5 ganglia, two pieces of celiac 
ganglia and four pieces of vagal nerves (cumulative specimens from cervical and thoracic 
portions) were obtained at routine post-mortem dissection from males who died without a 
history of any neuropsychiatric and endocrine illness. The age of the subjects ranged from 50 
to 71 years, and the time elapsed from death to removal of the ganglia was 10-42 h. After 
removal, the samples were stored on dry ice until homogenization. They were cut into small 
pieces and sonicated in 1 M HCl (1 ml HCl/100 mg wet weight tissue). The acid extracts were 
centrifugated and the supernatants were applied to SEP-PAK C18 cartridges (Waters Assoc., 
U.S.A.) which were then washed with 0.1% trifluoroacetic acid (TFA). The immunoreactive 
material was eluted from the cartridges with aqueous methanol containing 0.1% TFA. An 
aliquot of each eluted fraction was evaporated to dryness under a nitrogen stream and 
subjected to RIA analysis for oxytocin. The eluted immunoreactive material was 
characterized using a high-performance liquid chromatography (HPLC) system.  
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3. Results  
3.1 Immunoreactive oxytocin in the rat spinal cord 
3.1.1 Light microscopic distribution of oxytocin-immunoreactive fibers 
Each segment of the spinal cord contained oxytocin-immunoreactive fibers. However, 
no cell bodies were labelled. In the gray matter, the most intense immunoreactivity was 
observed at C8-T4 and T13-L4 levels. The superficial dorsal horn (Rexed laminae I and II) 
displayed moderate to intense immunoreactivity throughout the entire spinal cord. 
Immunoreactive fibers were found mainly in the marginal zone (Rexed lamina I) with 
extensions into the subjacent laminae II and III.  A longitudinally oriented network of labelled 
fibers was detected around the central canal. The strongest labelling was observed in the 
upper and lower thoracic, and lumbar segments. Some fibers were seen to closely appose the 
ependymal layer. A preferential accumulation of labelled fibers was observed in the dorsal 
gray commissure in the thoracic, lumbar and upper sacral spinal cord. At the same levels, 
strong patchy accummulations of fibers were found in the intermediolateral column. These 
immunoreactive patches were interconnected by a network of horizontally running fibers. The 
perikarya of the preganglionic autonomic areas seemed to be surrounded by immunoreactive 
fibers. In the lamina VII of segments C8-T4 and T13-L4, strong immunoreactive bundles at 
irregular intervals coursed between the dorsal gray commissure and the intermediolateral 
column. This location corresponded to the area of nucleus intercalatus spinalis; for 
designation of specific autonomic nuclei. Fibers around motoneurons of the anterior horn 
were labelled mostly in the C5-C7 and L4-L6 segments. The rest of the gray matter contained 
very few labelled fibers.   
In the white matter, the majority of labelled fibers were detected in the dorsal part of 
the lateral funiculus in the entire spinal cord. We frequently observed stained fibers in the 
Lissauer s tract in all spinal segments. Some of these fibers were found to enter the marginal 
zone of the dorsal horn. Fibers were often extending between the dorsal part of the lateral 
funiculus and superficial dorsal horn, Lissauer s tract, intermediolateral column and dorsal 
gray commissure. In the lateral funiculus, reactive fibers were seen to leave the 
intermediolateral column and appear around the preganglionic neurons of the pars funicularis 
of nucleus intermediolateralis.  
Numerous fibers formed a longitudinally oriented network observed in horizontal 
sections. This network was the densest below the pia mater, and some fibers did enter it. 
 10
Oxytocin-immunoreactive fibers were also seen close to the subarachnoid space at the 
Lissauer s tract and dorsal part of the lateral funiculus. Occasional fibers were labelled in the 
anterior funiculus, mostly in the lumbar segments. These fibers entered the anterior funiculus 
from the network around the central canal, and a few of them run to the surface of the ventral 
median fissure. The posterior funiculus contained only a few scattered reactive fibers.   
In horizontal sections of the spinal cord longitudinally oriented oxytocin-
immunoreactive networks were detected around the central canal, in the dorsal gray 
commissure, superficial dorsal horn, Lissauer s tract, dorsal part of the lateral funiculus and 
lateral funiculus.   
3.1.2 Electron micropscopic identification of oxytocin-immunoreactive terminals   
Oxytocin-immunoreactivity was seen in unmyelinated fibers of small diameter and 
axon terminals in the laminae I, II, VII and X of the spinal gray matter. No immunoreactive 
cell bodies were labelled. Oxytocin-containing axon terminals formed mainly axo-dendritic 
synapses. We also found a few axo-somatic synaptic contacts with presumptive neuronal cell 
bodies located in the ependymal lining of the central canal. In most cases, the electron dense 
peroxidase immunoprecipitate completely filled the cytoplasm of the axon terminals and 
masked the subcellular organelles and synaptic densities. When the reaction product was 
lightly distributed, it was possible to see that the immunoreactive terminals contained 
numerous small clear vesicles and a few large dense-cored vesicles.  
3.1.3 Quantitative distribution of oxytocin  
Our RIA measurements revealed that oxytocin was concentrated in the caudal regions 
of the rat spinal cord. The oxytocin content in the cervical spinal cord was significantly lower 
than those found in the thoracic, lumbar, sacral and coccygeal regions. The highest quantity 
was measured in the lumbar spinal cord   
3.1.4 Acute effect of peripheral histamine administration on spinal oxytocin content  
The i.p. injection of histamine induced a 36% decrease in oxytocin content in the rat 
spinal cord.  
3.2 Chromatographically identified oxytocin in the human peripheral nervous system 
Oxytocin-like immunoreactivity was detected in extracts of human sensory (spinal L5, 
Gasserian) ganglia, sympathetic (celiac) ganglia and peripheral nerves (nervus vagus) by 
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radioimmunoassay (RIA) specific to oxytocin and was characterized by high-performance 
liquid chromatography (HPLC). HPLC-RIA measurements demonstrated that the Gasserian, 
L5 ganglia and the celiac ganglia of humans contained significant levels of immunoreactive 
oxytocin. However, our results showed that the immunoreactive oxytocin migrated as two 
individual peaks. The first immunoreactive peak was eluted at the same position as the 
authentic oxytocin standard. The identity of the second immunoreactive peak is not known, 
but it might be a degradation product of oxytocin.   
4. Discussion  
This study was undertaken to examine the distribution of oxytocin in the spinal cord and 
reveal its occurence in various parts of the peripheral nervous system. Our results show that 
oxytocin is localized exclusively in axons, and the distribution of oxytocin-immunoreactive 
fibers in the spinal cord correlates with structures related to nociceptive, autonomic and motor 
functions. The oxytocin-immunoreactive fibers clearly display segmentally uneven 
distribution. The significant rise in oxytocin content in the thoracic, lumbar and sacral 
segments is associated with the dense innervation in the spinal autonomic centers. We 
conclude that the preferential sites of accumulation of oxytocin-containing fibers in the spinal 
cord bear close resemblance to the locations of sympathetic and parasympathetic 
preganglionic neurons, suggesting oxytocinergic modulation of autonomic functions. An 
important finding of this study is that oxytocin-containing fibers innervate the nucleus 
intermediolateralis pars funicularis in the lateral funiculus, which has not been noticed by 
previous investigators. Our results demonstrate that oxytocin-immunoreactive fibers get close 
to the internal and external liquor spaces of the spinal cord. Although at the light microscopic 
level, many fibers seemed to appose the ependyma of the central canal, the electron 
microscopic immunocytochemistry revealed only occasional synaptic contacts with 
presumptive neuronal perikarya in the ependymal layer. Our experiments also showed that 
some fibers from the lateral funiculus entered the pia mater. The close proximity of oxytocin-
containing fibers to the spinal liquor spaces suggests that their terminals may release oxytocin 
into the cerebrospinal fluid. This possibility is supported by physiological experiments in 
which electrical stimulation of the hypothalamic paraventricular nucleus yielded increased 
concentration of oxytocin in perfusates obtained from the subarachnoid space of the spinal 
cord. In accordance with our light microscopic results, in ultrathin electron microscopic 
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sections we found numerous oxytocin-immunoreactive axon profiles in the gray matter of the 
spinal cord, but could not detect labeled cell bodies. Our electron microscopic findings 
confirm the literature data that many labelled axon terminals made synaptic contacts with 
dendrites in the posterior horn, around the central canal and the autonomic areas of the spinal 
gray matter. Moreover, we also found a few axo-somatic synaptic contacts in the area of the 
central canal. Since the pre-embedding immunoperoxidase technique that we applied is not 
suitable for a more precise analysis of the subcellular structure of oxytocin-labeled synapses, 
we could not confirm the results of previous investigators showing that the immunolabelled 
presynaptic vesicles belong to the electron dense type.  
Several studies indicate the role of the central histaminergic system in the control of 
oxytocin and vasopressin secretion. However, the effect of peripheral histamine on the 
oxytocin and vasopressin content of the central nervous system has been less studied. Our 
results show that peripheral histamine administration can produce a significant decrease in the 
spinal content of oxytocin. The mechanism of the action of peripheral histamine 
administration on the spinal oxytocin system is not clear. Histamine may exert its effect 
through stimulation of histamine receptors in sensory ganglia and nerve endings, and/or 
through baroreceptor and chemoreceptor activity alterations in the vascular system. As a 
result, the neuronal impulses generated, we assume, can ultimately reach oxytocinergic 
neurons in the paraventricular nucleus projecting to the spinal cord. Alternatively, histamine 
may act on the paraventriculo-spinal oxytocinergic system via the circumventricular organs. 
Our RIA measurements revealed significant levels of immunoreactive oxytocin in 
selected samples of the human peripheral nervous system, including sensory (spinal L5, 
Gasserian) and sympathetic (celiac) ganglia as well as peripheral (vagal) nerves. HPLC 
showed that the immunoreactive oxytocin was eluted at the same position as the authentic 
oxytocin standard. Our results provide the first evidence for the presence of oxytocin in the 
human peripheral nervous system. The presence of oxytocin was later confirmed in human 
sympathetic paravertebral ganglia, too. The occurrence of neurohypohysial peptides has been 
detected in several components of the peripheral nervous system of mammals. It was found 
that a bioactive and immunoreactive vasopressin-like peptide is present in the sympathetic 
nervous system of the rat. Authentic arginine vasopressin and oxytocin were identified by 
chromatography in sensory neurones and peripheral nerves. Oxytocin was reported to be 
present in both the small dark and the large light sensory neurones of L5 dorsal root ganglia 
and to coexist with arginine vasopressin in the rat. Arginine-vasopressin-like 
immunoreactivity was axonally transported in the dorsal root and sciatic nerve. Furthermore, 
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observations obtained in animals neonatally treated with capsaicin suggests that vasopressin is 
located in primary afferent terminals in upper dorsal horn of the spinal cord. Finally, oxytocin 
and oxytocin receptor transcripts and protein have been recently found in the enteric nervous 
system. The origin and functional significance of oxytocin in the peripheral nervous system 
are not clear yet. Although it is very likely that oxytocin is synthesized locally in neurons of 
sensory and autonomic ganglia, further studies should be performed to confirm this 
assumption. The axonal transport of oxytocin from ganglion cells also remain to be studied. 
Although the great majority of oxytocin in the spinal cord has been shown to stem from the 
hypothalamic paraventricular nucleus, there is a minor amount the source of which is unclear. 
The possibility that it originates from dorsal root ganglion cells should thus be tested.  There 
are only scarce data available on the role of oxytocin in the peripheral nervous system. 
Oxytocin is thought to depress the ganglionic transmission in superior cervical ganglia. In 
other experiments it has been shown to activate intrathoracic ganglionic neurons involved in 
efferent sympathetic cardiac regulation. Further studied are obviously needed to elucidate the 
precise role and functional significance of oxytocin in different parts of the peripheral nervous 
system.  
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5. Summary   
We investigated the distribution of immunoreactive oxytocin in the rat spinal cord 
using immunocytochemistry and RIA. The presence of authentic oxytocin in the human 
peripheral nervous system was demonstrated by means of HPLC and RIA.  
By light microscopic immunohistochemistry, each segment of the spinal cord from 
cervical to coccygeal ones contained oxytocin-immunoreactive fibers. The Rexed laminae I 
and II of the dorsal horn showed moderate to intense immunoreactivity. A dense network was 
found around the central canal where some fibers apposed the ependyma. The autonomic 
centers of the spinal cord at the thoracolumbar and sacral segments were heavily innervated. 
Few fibers were seen around the motoneurons. In the white matter, the immunoreactivity was 
localized mainly in the dorsal part of the lateral funiculus, in the pars funicularis of the 
nucleus intermediolateralis and in a longitudinal network of the lateral funiculus below the 
spinal cord surface. Some fibers from this network were found to enter the pia mater.  
Our electron microscopic investigations showed that the oxytocin-immunoreactive 
fibers were unmyelinated and most of the immunoreactive axon terminals made synaptic 
contacts with dendrites. A few oxytocin-containing axon terminals were also observed 
synapsing with neronal somas located in the ependymal lining of the central canal.  
RIA measurements revealed that the oxytocin content was preferentially accumulated 
in the caudal regions of the rat spinal cord. The cervical spinal cord had lower oxytocin 
content than that found in either the thoracic, lumbar, sacral or coccygeal region.  
Experiments made with peripheral administration of histamine demonstrated that this 
agent can bring about a significant decrease in the oxytocin content of the rat spinal cord.  
Oxytocin immunoreactivity was detected in extracts of human spinal L5, Gasserian 
and celiac ganglia as well as vagus nerve by RIA and characterized by HPLC. HPLC/RIA 
examinations showed that a major part of the immunoreactive material co-eluted with a 
reference synthetic oxytocin, but in the extracts of spinal L5, Gasserian and celiac ganglia a 
second immunoreactive peak was also observed. The identity of the latter material is 
unknown, but it might well be a degradation product of oxytocin. 
In conclusion, our results demonstrate that the distribution of oxytocin in the rat spinal 
cord correlates with anatomic locations related to nociceptive, autonomic and motor 
functions. Oxytocin-containing axon terminals shown to make synaptic contacts with 
dendrites and cell somas are thought to be the structures through which oxytocin modulates 
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spinal functions. We assume that oxytocin-containing axon terminals situated in close 
proximity of spinal liquor spaces play a role in secreting oxytocin into the cerebrospinal fluid. 
Our experiments also showed that peripherally administered histamine alters oxytocin content 
in the spinal cord which may have relevance under physiological and/or pathological 
conditions. Finally, this study revealed the occurrence of oxytocin in various parts of the 
human peripheral nervous system. The morphological aspects and functional significance of 
this finding remain to be elucidated. 
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